Terms: = Pancreatic cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Prognosis
5 results:
1. pim-1 contributes to the malignancy of pancreatic cancer and displays diagnostic and prognostic value.
Xu J; Xiong G; Cao Z; Huang H; Wang T; You L; Zhou L; Zheng L; Hu Y; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2016 Sep; 35(1):133. PubMed ID: 27596051
[TBL] [Abstract] [Full Text] [Related]
2. Low tristetraprolin expression promotes cell proliferation and predicts poor patients outcome in pancreatic cancer.
Wei ZR; Liang C; Feng D; Cheng YJ; Wang WM; Yang DJ; Wang YX; Cai QP
Oncotarget; 2016 Apr; 7(14):17737-50. PubMed ID: 26894969
[TBL] [Abstract] [Full Text] [Related]
3. pim kinases: an overview in tumors and recent advances in pancreatic cancer.
Xu J; Zhang T; Wang T; You L; Zhao Y
Future Oncol; 2014 Apr; 10(5):865-76. PubMed ID: 24799066
[TBL] [Abstract] [Full Text] [Related]
4. pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor.
Wang C; Li HY; Liu B; Huang S; Wu L; Li YY
J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia-inducible proto-oncogene pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma.
Reiser-Erkan C; Erkan M; Pan Z; Bekasi S; Giese NA; Streit S; Michalski CW; Friess H; Kleeff J
Cancer Biol Ther; 2008 Sep; 7(9):1352-9. PubMed ID: 18708761
[TBL] [Abstract] [Full Text] [Related]
